GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patientsLihua Yu, Lihua Yang, Li Wu et al.|Journal of Cancer Research and Clinical Oncology|2021Cited by 84
Inhibition of <scp>miR</scp>‐181a attenuates sepsis‐induced inflammation and apoptosis by activating Nrf2 and inhibiting <scp>NF‐κB</scp> pathways via targeting <scp>SIRT1</scp>Wu Zhu, Qiong Chen|The Kaohsiung Journal of Medical Sciences|2020Cited by 22
GD2-specific Chimeric Antigen Receptor-modified T Cells for the treatment of Refractory and/or Recurrent Neuroblastoma in Pediatric PatientsLihua Yu, Lihua Yang, Lulu Huang et al.|Research Square|2021Cited by 7